Biological and clinical characteristics of ETV6::RUNX1-like ALL
Refining how doctors recognize a tricky leukemia subtype improves risk prediction and could guide more targeted treatment choices.
This large multicenter study characterizes ETV6::RUNX1-like ALL — a molecular subtype lacking the canonical fusion but showing similar features — across biological and clinical dimensions. Findings refine the classification of this ALL subset and may inform risk stratification and therapeutic decisions.
What the study was
- Study design
- Multicenter retrospective cohort study
- Population
- Pediatric and adult ALL patients with ETV6::RUNX1-like molecular features
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- HemaSphere
Why it surfaced
Large multicenter ALL characterization study in HemaSphere; foundational for precision medicine in ALL.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.